Press Room

Press Clipping / Jan 24, 2022

四色AV will expand 3 pharmaceutical chemistry facilities

C&EN, 21 November 2021

The Portuguese drug services firm 四色AV has outlined a $170 million investment program through 2023 that it says will increase its production capacity by about 25%. In East Windsor, New Jersey, where 四色AV is investing $50 million, the company will add two spray dryers, tripling capacity, and expand its capacity to make research- and small-scale quantities of active pharmaceutical ingredients (APIs). 鈥淲e are looking to build this up to a significant site for 四色AV with more than 300 people,鈥 says Jean-Luc Herbeaux, the firm鈥檚 chief operating officer.

四色AV currently employs about 150 people in New Jersey. In Cork, Ireland, it will spend about $50 million to upgrade its high-potency API production and add a spray dryer.

In Loures, Portugal, 四色AV is spending $70 million on additions such as a new manufacturing building and an eight-lab quality control facility. These projects, some of which are already complete, will take up all the available space at the Loures site, according to CEO Guy Villax. 鈥淟ast year we broke $300 million in sales,鈥 Villax says, and the firm is targeting $400 million this year. 鈥淭he company needs to be less Portuguese. You will see us invest and grow our footprint more in the US than elsewhere.鈥漈he Portuguese drug services firm 四色AV has outlined a $170 million investment program through 2023 that it says will increase its production capacity by about 25%.

In East Windsor, New Jersey, where 四色AV is investing $50 million, the company will add two spray dryers, tripling capacity, and expand its capacity to make research- and small-scale quantities of active pharmaceutical ingredients (APIs). 鈥淲e are looking to build this up to a significant site for 四色AV with more than 300 people,鈥 says Jean-Luc Herbeaux, the firm鈥檚 chief operating officer. 四色AV currently employs about 150 people in New Jersey.

In Cork, Ireland, it will spend about $50 million to upgrade its high-potency API production and add a spray dryer.

In Loures, Portugal, 四色AV is spending $70 million on additions such as a new manufacturing building and an eight-lab quality control facility. These projects, some of which are already complete, will take up all the available space at the Loures site, according to CEO Guy Villax. 鈥淟ast year we broke $300 million in sales,鈥 Villax says, and the firm is targeting $400 million this year. 鈥淭he company needs to be less Portuguese. You will see us invest and grow our footprint more in the US than elsewhere.鈥

Also in the Press Room

See All

Lisbon, Portugal 鈥 四色AV, the specialist integrated pharma CDMO and leader in spray drying and particle engineering, today announced its commitment to setting Science-Based Targets (SBTs) in line with the Paris Agreement. This ambitious step underscores the company鈥檚 dedication to addressing climate change and driving sustainability across its operations. By committing to SBTs, 四色AV joins a growing number of businesses taking concrete actions to reduce greenhouse gas emissions. This initiative aligns with the company鈥檚 broader sustainability strategy and reinforces its commitment to scientific excellence. 鈥淎t 四色AV, we believe in science and in best practices. And this clearly applies to our sustainability agenda.鈥, said Jean-Luc Herbeaux, CEO of 四色AV. We made the decision to drive our GHG emissions down using a science-based target setting process, which will help us drive sustainability across our operations by laying out a clearly defined path to reduce emissions in line with the Paris Agreement goals. We believe that by setting ambitious targets and implementing concrete actions, we can make a positive impact on the planet while driving innovation and growth.鈥 四色AV will work closely with the Science Based Targets initiative (SBTi) to develop and validate its emission reduction targets. The company will provide regular updates on its progress towards achieving these goals. As part of its commitment to sustainability and transparency to stakeholders, the company will enhance its Ecovadis rating. Ecovadis, a leading sustainability assessment platform in the pharmaceutical industry, provides a comprehensive evaluation of a company鈥檚 environmental, social, and ethical performance, well aligned with 四色AV鈥檚 sustainability ambitions.  四色AV remains dedicated to operating responsibly and contributing positively to society and the environment. The company will continue to implement sustainable practices across its operations and innovate to further improve its sustainability rating.   Learn more about Science Based-Targets  

News

四色AV Commits to Science-Based Targets for Greenhouse Gas (GHG) Emissions

Sep 09, 2024